Related Experiment Video
Updated: May 29, 2026
07:23
Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability
Published on: August 6, 2021
[Risk factors in central retinal vein occlusion]
1Clinica de Oftalmologie Cluj-Napoca.
Oftalmologia (Bucharest, Romania : 1990)
|September 6, 2011
Summary
Central retinal vein occlusion shares risk factors with cardiovascular diseases, including hypertension and diabetes. Hyperhomocysteinemia and glaucoma are key factors, while anticoagulant therapy may worsen outcomes.
Area of Science:
- Ophthalmology
- Vascular Medicine
Context:
- Central retinal vein occlusion (CRVO) shares risk factors with cardiovascular diseases.
- Arteriosclerosis, arterial systemic hypertension, diabetes mellitus, and dyslipidemia are common risk factors.
- Hyperhomocysteinemia is a significant risk factor for arteriosclerosis and venous occlusions.
Purpose:
- To identify and elucidate the risk factors associated with central retinal vein occlusion.
- To explore the role of hyperhomocysteinemia and ocular hypertension in CRVO pathogenesis.
- To evaluate the impact of anticoagulant and antiplatelet therapies on CRVO outcomes.
Summary:
- CRVO pathogenesis involves factors similar to cardiovascular diseases, including arteriosclerosis, hypertension, diabetes, and dyslipidemia.
- Hyperhomocysteinemia plays a crucial role in arteriosclerosis and local venous/arterial occlusions.
- Ocular hypertension and glaucoma are significantly linked to CRVO development.
- Anticoagulant and antiplatelet therapies do not demonstrate beneficial effects and may adversely impact visual outcomes in CRVO patients.
Impact:
- Highlights the importance of managing systemic vascular risk factors for CRVO prevention.
- Underscores the need for further research into the role of hyperhomocysteinemia and glaucoma in CRVO.
- Informs clinical practice regarding the use of anticoagulant and antiplatelet agents in CRVO management.
Related Concept Videos
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
01:25Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...